Symbol="GMAB"
AssetType="Common Stock"
Name="Genmab AS"
Description="Genmab A / S develops antibody therapies for the treatment of cancer and other diseases mainly in Denmark. The company is headquartered in Copenhagen, Denmark."
CIK="1434265"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="TOLDBODGADE 33, 1253 COPENHAGEN K, DK"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="24786895000"
EBITDA="6930000000"
PERatio="30.48"
PEGRatio="1.21"
BookValue="44.05"
DividendPerShare="0"
DividendYield="0"
EPS="1.24"
RevenuePerShareTTM="25.07"
ProfitMargin="0.29"
OperatingMarginTTM="0.401"
ReturnOnAssetsTTM="0.138"
ReturnOnEquityTTM="0.178"
RevenueTTM="16366000000"
GrossProfitTTM="14595000000"
DilutedEPSTTM="1.24"
QuarterlyEarningsGrowthYOY="-0.281"
QuarterlyRevenueGrowthYOY="0.328"
AnalystTargetPrice="44.41"
TrailingPE="30.48"
ForwardPE="35.34"
PriceToSalesRatioTTM="2.463"
PriceToBookRatio="8.01"
EVToRevenue="2.203"
EVToEBITDA="3.589"
Beta="0.655"
num_52WeekHigh="47.5"
num_52WeekLow="31.4"
num_50DayMovingAverage="38.98"
num_200DayMovingAverage="40.05"
SharesOutstanding="652750000"
DividendDate="None"
ExDividendDate="None"
symbol="GMAB"
open="38.21"
high="38.39"
low="37.61"
price="37.62"
volume="220368.00"
latest_trading_day="2023-08-10"
previous_close="37.80"
change="-0.18"
change_percent="-0.4762%"
aroon_positive_momentum_days="62"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="62"
Volume_recent_avg="452725"
Change_recent_avg="0.05"
Delta_recent_avg="0.58"
Variance_recent_avg="0.29"
Change_ratio_recent_avg="0.12"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_10"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="62"
Aroon_momentum_negative="38"
image_negative_thumbnail_id_1="118"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0058.jpeg"
image_negative_thumbnail_id_2="518"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0087.jpeg"
image_neutral_thumbnail_id_1="557"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0042.jpeg"
image_neutral_thumbnail_id_2="566"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_positive_thumbnail_id_1="646"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0062.jpeg"
image_positive_thumbnail_id_2="670"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0038.jpeg"
image_professor_thumbnail_id_1="1167"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
image_professor_thumbnail_id_2="1200"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
